Advertisement
Veracyte, Inc.

Veracyte, Inc. (VCYT) Stock Overview

Explore Veracyte, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

VCYTโ—NASDAQ
HealthcareBiotechnology
$53.63
$2.34(4.56%)
U.S. Market is Open ยท 10:47
Advertisement

Veracyte, Inc. (VCYT)

Meyka AI Score

Z

Key Financials

Market Cap4.3B
P/E Ratio47.76
EPS (TTM)$1.12
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$46.89
3 Months$40.57
1 Year Target$47.07

VCYT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Veracyte, Inc. (VCYT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.25, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $47.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 47.76 and a market capitalization of 4.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.56%
5-Day Change
12.88%
1-Month Change
29.23%
3-Month Change
61.15%
6-Month Change
27.57%
Year-to-Date (YTD) Change
27.39%
1-Year Change
99.96%
3-Year Change
104.30%
5-Year Change
43.13%
All-Time (Max) Change
304.75%

Contact Information

650 243 6300
6000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

824 Employees
IPO DateOct 30, 2013
CountryUS
Actively Trading

Frequently Asked Questions